---
document_datetime: 2023-09-21 18:36:05
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/insulatard-epar-all-authorised-presentations_en.pdf
document_name: insulatard-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 2.1256207
conversion_datetime: 2025-12-29 21:26:52.993337
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name    | Strength   | Pharmaceutical form      | Route of administration   | Immediate Packaging                 | Content (concentration)   | Pack size                   |
|------------------|--------------------|------------|--------------------------|---------------------------|-------------------------------------|---------------------------|-----------------------------|
| EU/1/02/233/001  | Insulatard         | 40 iu/ml   | Suspension for injection | Subcutaneous use          | Vial (glass)                        | 10 ml (1.4 mg/ml)         | 1 vial                      |
| EU/1/02/233/002  | Insulatard         | 40 iu/ml   | Suspension for injection | Subcutaneous use          | Vial (glass)                        | 10 ml (1.4 mg/ml)         | 5 vials                     |
| EU/1/02/233/003  | Insulatard         | 100 iu/ml  | Suspension for injection | Subcutaneous use          | Vial (glass)                        | 10 ml (3.5 mg/ml)         | 1 vial                      |
| EU/1/02/233/004  | Insulatard         | 100 iu/ml  | Suspension for injection | Subcutaneous use          | Vial (glass)                        | 10 ml (3.5 mg/ml)         | 5 vials                     |
| EU/1/02/233/005  | Insulatard Penfill | 100 iu/ml  | Suspension for injection | Subcutaneous use          | Cartridge (glass)                   | 3 ml (3.5 mg/ml)          | 1 cartridge                 |
| EU/1/02/233/006  | Insulatard Penfill | 100 iu/ml  | Suspension for injection | Subcutaneous use          | Cartridge (glass)                   | 3 ml (3.5 mg/ml)          | 5 cartridges                |
| EU/1/02/233/007  | Insulatard Penfill | 100 iu/ml  | Suspension for injection | Subcutaneous use          | Cartridge (glass)                   | 3 ml (3.5 mg/ml)          | 10 cartridges               |
| EU/1/02/233/010  | Insulatard InnoLet | 100 iu/ml  | Suspension for injection | Subcutaneous use          | Cartridge (glass) in pre-filled pen | 3 ml (3.5 mg/ml)          | 1 pre-filled pen            |
| EU/1/02/233/011  | Insulatard InnoLet | 100 iu/ml  | Suspension for injection | Subcutaneous use          | Cartridge (glass) in pre-filled pen | 3 ml (3.5 mg/ml)          | 5 pre-filled pens           |
| EU/1/02/233/012  | Insulatard InnoLet | 100 iu/ml  | Suspension for injection | Subcutaneous use          | Cartridge (glass) in pre-filled pen | 3 ml (3.5 mg/ml)          | 10 pre-filled pens          |
| EU/1/02/233/013  | Insulatard FlexPen | 100 iu/ml  | Suspension for injection | Subcutaneous use          | Cartridge (glass) in pre-filled pen | 3 ml (3.5 mg/ml)          | 1 pre-filled pen            |
| EU/1/02/233/014  | Insulatard FlexPen | 100 iu/ml  | Suspension for injection | Subcutaneous use          | Cartridge (glass) in pre-filled pen | 3 ml (3.5 mg/ml)          | 5 pre-filled pens           |
| EU/1/02/233/015  | Insulatard FlexPen | 100 iu/ml  | Suspension for injection | Subcutaneous use          | Cartridge (glass) in pre-filled pen | 3 ml (3.5 mg/ml)          | 10 pre-filled pens          |
| EU/1/02/233/016  | Insulatard         | 40 iu/ml   | Suspension for injection | Subcutaneous use          | Vial (glass)                        | 10 ml (1.4 mg/ml)         | 5 (5 x 1) vials (multipack) |
| EU/1/02/233/017  | Insulatard         | 100 iu/ml  | Suspension for injection | Subcutaneous use          | Vial (glass)                        | 10 ml (3.5 mg/ml)         | 5 (5 x 1) vials (multipack) |